raloxifene hydrochloride has been researched along with Hypocalcemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Stepan, JJ; Zikan, V | 1 |
Jerums, G; MacIsaac, RJ; Seeman, E; Varadarajan, S; Vu, TD | 1 |
1 trial(s) available for raloxifene hydrochloride and Hypocalcemia
Article | Year |
---|---|
Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.
Topics: Aged; Aged, 80 and over; Alendronate; Area Under Curve; Biomarkers; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Chelating Agents; Collagen Type I; Edetic Acid; Etidronic Acid; Female; Humans; Hypocalcemia; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptides; Raloxifene Hydrochloride; Risedronic Acid | 2009 |
1 other study(ies) available for raloxifene hydrochloride and Hypocalcemia
Article | Year |
---|---|
Hypocalcemia induced by raloxifene.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Female; Humans; Hypocalcemia; Mass Screening; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Vitamin D Deficiency | 2012 |